Loading…
Loading…
MDLN (Medline Inc.) is a recent IPO.
It began trading on December 17, 2025, giving it less than a year of public history. Many charts and metrics below are sparse or empty until more price, financial, and analyst history accumulates — the affected sections are flagged individually so you can tell limited history from missing data.
| RMD | ResMed Inc. | $192.91 | $28.0B |
| COO | The Cooper Companies, Inc. | $70.50 | $13.7B |
| AVTR | Avantor, Inc. | $10.95 | $7.5B |
| BLCO | Bausch + Lomb Corporation | $15.95 | $5.7B |
| NTSK | Netskope, Inc. Class A Common Stock | $11.96 | $4.8B |
| LMAT | LeMaitre Vascular, Inc. | $98.81 | $2.3B |
| KMTS | Kestra Medical Technologies, Ltd. | $20.89 | $1.2B |
| LMRI | Lumexa Imaging Holdings, Inc. Common Stock | $10.65 | $1.0B |
| INFU | InfuSystem Holdings, Inc. | $8.90 | $179.6M |
| BRCB | Black Rock Coffee Bar, Inc. | $7.97 | $143.6M |